Placental mesenchymal dysplasia

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 1, 2007, Pages 131-137

  Parveen, Zahida ^a,c   Tongson Ignacio, Jane Elaine ^a,d   Fraser, Cory R ^a   Killeen, Jeffery L ^b   Thompson, Karen S ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

^c UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; CYTOGENETICS; DATA BASE; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MEDLINE; MICROSCOPY; PLACENTA DISORDER; PLACENTA MESENCHYMAL DYSPLASIA; PREGNANCY TERMINATION; REVIEW;

BECKWITH-WIEDEMANN SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDATIDIFORM MOLE; MESODERM; PLACENTA; PLACENTA DISEASES; PLACENTATION; PREGNANCY;

EID: 33846646168     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Moscoso G, Jauniaux E, Hustin J. Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity? Pathol Res Pract. 1991;187:324-328.
2. Chen CP, Chern SR, Wang TY, Huang ZD, Huang MC, Chuang CY. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Hum Reprod. 1997;12:2553-2556.
3. Kuwabara Y, Shima Y, Araki T, Shin S. Mesenchymal stem villous hyperplasia of the placenta and fetal growth restriction. Obstet Gynecol. 2001;98:940-943.
4. Laberge JM, Patenaude Y, Desilets V, et al. Large hepatic mesenchymal hamartoma leading to mid-trimester fetal demise. Fetal Diagn Ther. 2005;20:141-145.
5. Hojberg KE, Aagaard J, Henriques U, Sunde L. Placental vascular malformation with mesenchymal hyperplasia and a localized chorioangioma: a rarity simulating partial mole. Pathol Res Pract. 1994;190:808-813.
6. Lage JM. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content and fetal omphaloceles: possible association with Beckwith-Wiedemann syndromes. Hum Pathol. 1991;22:591-597.
7. Paradinas FJ, Sebire NJ, Fisher RA, et al. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology. 2001;39:447-454.
8. Arizawa M, Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Cong Anomal. 2002;42:309-317.
9. Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DOC. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn. 2005;25:187-192.
10. Jauniaux E, Nicolaides KH, Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta. 1997;18:701-706.
11. Maher ER, Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest. 2000;105:247-252.
12. Fox H. Fibrosis of placental villi. J Pathol Bacteriol. 1968;95:573-579.
13. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet [serial online]. Available at: http://jmg.bmjjournals.com/cgi/content/abstract/jmg.2005. 033571v1. Accessed December 20, 2005.
14. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 1989;44:720-723.
15. Matsuoka S, Thompson JS, Edwards MC, et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci U S A. 1996;93:3026-3030.
16. Hatada I, Ohashi H, Fukushima Y, et al. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet. 1996;14:171-173.
17. Bhuiyan ZA, Yatsuki H, Sasaguri T, et al. Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome. Hum. Genet. 1999;104:205-210.
18. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991;64:849-859.
19. Weksberg R, Shen DR, Fei YL, Song QL, Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993;5:143-150.
20. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted Igf2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994;8:2953-2963.
21. Zhang P, Liegeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997;387:151-158.
22. Yamada Y, Nezu J, Shimane M, Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997;42:483-488.
23. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996;15:290-298.
24. Reinhart RD, Wells WA, Harris RD. Focal aneurysmal dilatation of subchorionic vessels simulating chorioangioma. Ultrasound Obstet Gynecol. 1999;13:147-149.
25. Katz VL, Blanchard GF, Watson WJ, Miller RC, Chescheir NC. The clinical implications of subchorionic placental lucencies. Am J Obstet Gynecol. 1991;164:99-100.
26. Lokan J, Chan YF. Placental mesenchymal dysplasia. Pathology. 2002;34:375-383.
27. Ohyama M, Kojyo T, Gotoda H, Sato T, Ijiri R, Tanaka Y. Mesenchymal dysplasia of the placenta. Pathol Int. 2000;50:759-764.
28. Sander CM. Angiomatous malformation of placental chorionic stem vessels and pseudo-partial molar placentas: report of five cases. Pediatr Pathol. 1993;13:621-633.
29. Khong TY. Placental vascular development and neonatal outcome. Semin Neonatal. 2004;9:255-263.
30. Matsui H, Iitsuka Y, Yamazawa K, et al. Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol Int. 2003;53:810-813.
31. Chan YF, Sampson A. Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole. Aust N Z J Obstet Gynaecol. 2003;43:475-479.
32. Benirschke K, Kaufmann P. Pathology of the Human Placenta. 4th ed. New York, NY: Springer Verlag; 2000.
33. Castrillon DH, Sun D, Weremowicz S, Fisher RA, Crum CP, Genest DR. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25:1225-1230.
34. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57Kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269-276.
35. Astner A, Schwinger E, Caliebe A, Jonat W, Gembruch U. Sonographically detected fetal and placental abnormalities associated with trisomy 16 confined to the placenta: a case report and review of the literature. Prenat Diagn. 1998;18:1308-1315.
36. Cohen MM Jr. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol. 2005;8:287-304.
37. Furuhashi M, Oda H, Nakashima T. Hydrops of placental stem villi complicated with fetal congenital adrenal hyperplasia. Arch Gynecol Obstet. 2000;264:101-104.
38. Gibson BR, Muir-Padilla J, Champeaux A, Suarez ES. Case report: mesenchymal dysplasia of the placenta. Placenta. 2004;25:671-672.
39. Carta M, Maresi E, Giuffrè M, et al. Congenital hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta: case report. J Pediatr Surg. 2005;40:e37-39.
40. McCowan L, Becroft D. Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol. 1994;83:813-817.